Clinical Coagulation, Malmö
381 – 390 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
- Contribution to journal › Debate/Note/Editorial
-
Mark
Bone Mineral Density in Haemophilila: A Treatment Outcome
- Thesis › Doctoral thesis (compilation)
-
Mark
Quality of life, physical function and MRI T2*in elderly low-risk MDS patients treated to a haemoglobin level of >= 120 g/L with darbepoetin alfa +/- filgrastim or erythrocyte transfusions
- Contribution to journal › Article
-
Mark
The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
- Contribution to journal › Published meeting abstract
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
- Contribution to journal › Article
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
- Contribution to journal › Article
-
Mark
The international factor IX treatment network survey
- Contribution to journal › Published meeting abstract
-
Mark
Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
- Contribution to journal › Article
-
Mark
Haematuria and hypertension in haemophilia - the H3 study
- Contribution to journal › Published meeting abstract
-
Mark
Bone density and health-related quality of life in adult patients with severe haemophilia.
- Contribution to journal › Article